RareWays is a research directory. It helps you understand the science. It is not medical advice. Always discuss your care options with your healthcare team.
Coverage: 2020-01-01 onwards, with up to 300 results per query from PubMed and Europe PMC and separate limits on other sources. This is a selected index, not a complete literature search.
Updates are delayed or unverified. Check original sources for the latest information.
Your saved research and appointment questionsView recorded trial and retraction changes
Autoimmune Hepatitis: Research Summary
Printed from RareWays (rareways.org)
For general awareness only. Not medical advice. Discuss all care options with your healthcare team.
5 Most Recent Research Articles
- 1.
ACUTE ON CHRONIC LIVER FAILURE – OVERLAP SYNDROME ( AUTOIMMUNE HEPATITIS WITH PRIMARY SCLEROSING CHOLANGITIS)
Akhila D. C. et al., Zenodo (CERN European Organization for Nuclear Research) (16 October 2026)
https://doi.org/10.5281/zenodo.23410460
- 2.
Immunoglobulin G and liver stiffness in autoimmune hepatitis: Timing matters more than biochemical correction.
Niezen Sebastian et al., Clinical and translational gastroenterology (16 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42886068/
- 3.
Autoimmune hepatitis following long-term denosumab therapy in a patient with Hashimoto thyroiditis
(16 October 2026)
https://europepmc.org/search?query=Autoimmune%20hepatitis%20following%20long-term%20denosumab
- 4.
Azathioprine versus mycophenolate mofetil in treatment-naive autoimmune hepatitis: 3-year follow-up of the CAMARO-trial.
Slooter Charlotte D et al., JHEP reports : innovation in hepatology (15 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42880409/
- 5.
Corticosteroid Exposure in Autoimmune Hepatitis: Early Toxicity, Cumulative Burden and Associations With Long-Term Patient-Reported Outcomes.
Gentry Elizabeth et al., Alimentary pharmacology & therapeutics (14 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42875878/
Clinical Trials : Australian Sites
Ask your doctor whether you or your child may be eligible for any of these trials. Each has its ID and full eligibility criteria at the link shown.
- 1.
Effect of RO7049665 on the Time to Relapse Following Steroid Tapering in Participants With Autoimmune Hepatitis (AIH)
NCT04790916 · TERMINATED · Phase 2 · Hoffmann-La Roche
Ages 18 to 75
https://clinicaltrials.gov/study/NCT04790916
Source: RareWays research directory. Data from PubMed, Europe PMC, OpenAlex, ClinicalTrials.gov.
Always verify information with your healthcare team before making any decisions about your care.
Autoimmune Hepatitis
Autoimmune hepatitis is a rare long-term liver condition in which the immune system attacks the person's own liver cells, causing inflammation that can lead to scarring if untreated. Symptoms may include tiredness, joint aches, nausea and jaundice, though some people have none at first. Treatment usually involves steroids and other immune-suppressing medicines, with regular monitoring of liver blood tests.
This overview is general information, not an individual medical assessment. Research is selected automatically and may include mismatches. How we select and explain research.
Most Recent Research
Acute-on-chronic liver failure (ACLF) is a clinical syndrome characterized by an acute deterioration of liver function in patients with pre-existing chronic liver disease, leading to liver failure, organ dysfunction, and high short-term mortality. It is commonly associated with jaundice, coagulopathy, and the development of complications such as hepatic encephalopathy and ascites . Autoimmune hepatitis (AIH)–primary sclerosing cholangitis (PSC) overlap syndrome is a rare form of autoimmune liver disease in which features of both hepatocellular inflammation, typical of AIH, and cholestatic bile duct injury, characteristic of PSC, coexist. This overlap results in a complex clinical presentation and may predispose patients to rapid disease progression and liver failure . A 52 year old male was admitted to gastroenterology department with the complaints of fatigue, generalized pruritis . He has history of jaundice since last 3 months. The patient had past medical history of Type II Diabetes mellitus, CKD, DVT (around 8 months back). According to the physical examination, symptoms, diagnostic (Liver biopsy) and laboratory investigation (EBV PCR positive), the patient was diagnosed with Acute On Chronic Liver Failure – Overlap Syndrome (Autoimmune Hepatitis With Primary Sclerosing Cholangitis) and managed with IV antibiotic, oral steroid, and liver supportive medication.
Common Questions
What is Autoimmune Hepatitis?
Autoimmune hepatitis is a rare long-term liver condition in which the immune system attacks the person's own liver cells, causing inflammation that can lead to scarring if untreated. Symptoms may include tiredness, joint aches, nausea and jaundice, though some people have none at first. Treatment usually involves steroids and other immune-suppressing medicines, with regular monitoring of liver blood tests.
How many clinical trials are available for Autoimmune Hepatitis?
RareWays currently indexes 40 clinical trials for Autoimmune Hepatitis, of which 5 are actively recruiting. These counts cover indexed trials across countries, not just your country. An Australian site does not necessarily mean that site is recruiting. Check locations, eligibility and current availability with the study team.
Where does the research data for Autoimmune Hepatitis come from?
RareWays aggregates research from PubMed, Europe PMC, OpenAlex, and ClinicalTrials.gov. Data is refreshed automatically every day. All articles and trials link directly to their original sources.
Get research updates
Monthly email when new findings are published for Autoimmune Hepatitis.
Your email and selected disease are stored for these updates. Unsubscribe any time. Privacy and deletion.
This information is for general awareness only.
For guidance specific to your situation, please speak with your healthcare team.